CLCN2 and constipation disorder: Lubiprostone is a pharmacological agent used in the treatment of constipation [3] that has been proposed to act by promoting intestinal electrolyte and fluid secretion through the activation of Cl− channel ClC-2 [4], a mechanism that is now disputed [5,56].